ArticleMolecular & cellular proteomics : MCP2013

Quantitative proteomics with siRNA screening identifies novel mechanisms of trastuzumab resistance in HER2 amplified breast cancers.

Alaina P Boyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.